Sweet dreams: glycosylation controls tumor cell dormancy

Research output: Contribution to journalShort surveypeer-review


In a recent study in Cancer Cell, Sreekumar et al. used therapy-associated breast cancer mouse models as well as in vitro dormancy models to identify extracellular matrix (ECM)-related tumor cell-autonomous mechanisms of dormancy in residual tumor cells (RTCs). The study reveals an important role of the glycosylation of proteoglycans in sustaining dormancy and opens the door to leverage this biology to eliminate RTCs and prevent recurrence.

Original languageEnglish
Pages (from-to)180-181
Number of pages2
JournalTrends in Cancer
Issue number3
StatePublished - Mar 2024


  • dormancy
  • extracellular matrix
  • glycosylation
  • metastasis


Dive into the research topics of 'Sweet dreams: glycosylation controls tumor cell dormancy'. Together they form a unique fingerprint.

Cite this